Status:
ENROLLING_BY_INVITATION
Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis
Lead Sponsor:
Kafrelsheikh University
Conditions:
Intractable Allergic Rhinitis
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
This study aims to compare the outcomes of posterior nasal nerve neurectomy in patients with resistant Allergic rhinitis by using three different methods ( surgical resection vs radiofrequency ablatio...
Eligibility Criteria
Inclusion
- Patients aged 16 to 65 years, fit for surgery, diagnosed as moderate to severe persistent Allergic Rhinitis, as per the ARIA guidelines having 3 or more of the typical symptoms of Allergic Rhinitis including nasal discharge, repeated attacks of sneezing, nasal itching and nasal obstruction.
Exclusion
- • Patients with Coexisting nasal pathologies that could influence the outcomes of the surgery like: chronic granulomatous diseases of the nose, nasal tumors, chronic sinsitis with or without nasal polyps, etc.
- Patients who had used topical steroid nasal spray, oral or topical antihistamines, oral leukotriene antagonists, oral or tobical nasal decongestants in the last 2 weeks.
- Immunocompromised patients, Systemic disease affecting prognosis such as diabetes mellitus, hypertension,chronic liver failure or heart failure.
- Unwillingness for endoscopic surgery.
- Patients younger than 18 years of age.
- Patients who are unfit for general anesthesia.
- Previous history of nasal surgery
Key Trial Info
Start Date :
April 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06887842
Start Date
April 25 2025
End Date
May 1 2026
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
kafrelsheikh University Hospitals
Kafrelsheikh, Egypt